Genetic instabilities in human cancers (original) (raw)
Loeb, L. A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res.51, 3075–3079 (1991). CASPubMed Google Scholar
Hartwell, L. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell71, 543–546 (1992). CASPubMed Google Scholar
Tomlinson, I. P., Novelli, M. R. & Bodmer, W. F. The mutation rate and cancer. Proc. Natl Acad. Sci. USA93, 14800–14803 (1996). ADSCASPubMedPubMed Central Google Scholar
Almoguera, C. et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell53, 549–554 (1988). CASPubMed Google Scholar
Mitelman, F., Johansson, B. & Mertens, F. Catalog of Chromosome Aberrations in CancerVol. 2(Wiley-Liss, New York, (1994)). Google Scholar
Wang, S. I. et al. Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res.57, 4183–4186 (1997). CASPubMed Google Scholar
Zhuang, Z. et al. Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas. Nature Genet.20, 66–69 (1998). CASPubMed Google Scholar
Nowell, P. C. Genetic alterations in leukemias and lymphomas: impressive progress and continuing complexity. Cancer Genet. Cytogenet.94, 13–19 (1997). CASPubMed Google Scholar
Brodeur, G. M. & Hogarty, M. D. in The Genetic Basis of Human Cancer 1st ednVol. 1(eds Kinzler, K. W. & Vogelstein, B.) 161–179 (McGraw-Hill, New York, (1998)). Google Scholar
Seeger, R. C. et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med.313, 1111–1116 (1985). CASPubMed Google Scholar
Kauffmann-Zeh, A. et al. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature385, 544–548 (1997). ADSCASPubMed Google Scholar
Kunkel, T. A. DNA-mismatch repair. The intricacies of eukaryotic spell-checking. Curr. Biol.5, 1091–1094 (1995). CASPubMed Google Scholar
Sia, E. A., Jinks-Robertson, S. & Petes, T. D. Genetic control of microsatellite stability. Mutat. Res.383, 61–70 (1997). CASPubMed Google Scholar
Cleaver, J. E. Defective repair replication of DNA in xeroderma pigmentosum. Nature218, 652–656 (1968). ADSCASPubMed Google Scholar
De Weerd-Kastelein, E. A., Keijzer, W. & Bootsma, D. Genetic heterogeneity of xeroderma pigmentosum demonstrated by somatic cell hybridization. Nat. New Biol.238, 80–83 (1972). CASPubMed Google Scholar
Bootsma, D., Kraemer, K. H., Cleaver, J. E. & Hoeijmakers, J. H. J. in The Genetic Basis of Human Cancer(eds Kinzler, K. W. & Vogelstein, B.) 245–274 (McGraw-Hill, New York, (1998)). Google Scholar
Wood, R. D. DNA repair in eukaryotes. Annu. Rev. Biochem.65, 135–167 (1996). CASPubMed Google Scholar
Feinberg, A. P. & Coffey, D. S. Organ site specificity for cancer in chromosomal instability disorders. Cancer Res.42, 3252–3254 (1982). CASPubMed Google Scholar
Kraemer, K. H., Lee, M. M. & Scotto, J. DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum. Carcinogenesis5, 511–514 (1984). CASPubMed Google Scholar
Ames, B. N. & Gold, L. S. Endogenous mutagens and the causes of aging and cancer. Mutat. Res.250, 3–16 (1991). CASPubMed Google Scholar
Peinado, M. A., Malkhosyan, S., Velazquez, A. & Perucho, M. Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase chain reaction. Proc. Natl Acad. Sci. USA89, 10065–10069 (1992). ADSCASPubMedPubMed Central Google Scholar
Ionov, Y., Peinado, M. A., Malkhosyan, S., Shibata, D. & Perucho, M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature363, 558–561 (1993). ADSCASPubMed Google Scholar
Thibodeau, S. N., Bren, G. & Schaid, D. Microsatellite instability in cancer of the proximal colon. Science260, 816–819 (1993). ADSCASPubMed Google Scholar
Aaltonen, L. A. et al. Clues to the pathogenesis of familial colorectal cancer. Science260, 812–816 (1993). ADSCASPubMed Google Scholar
Peltomaki, P. et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science260, 810–812 (1993). ADSCASPubMed Google Scholar
Lindblom, A., Tannergard, P., Werelius, B. & Nordenskjold, M. Genetic mapping of a second locus predisoposing to hereditary non-polyposis colon cancer. Nature Genet.5, 279–282 (1993). CASPubMed Google Scholar
Strand, M., Prolla, T. A., Liskay, R. M. & Petes, T. D. Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature365, 274–276 (1993). ADSCASPubMed Google Scholar
Fishel, R. et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell75, 1027–1038 (1993). CASPubMed Google Scholar
Leach, F. S. et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell75, 1215–1225 (1993). CASPubMed Google Scholar
Bronner, C. E. et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature368, 258–261 (1994). ADSCASPubMed Google Scholar
Papadopoulos, N. et al. Mutation of a mutL homolog in hereditary colon cancer. Science263, 1625–1629 (1994). ADSCASPubMed Google Scholar
Parsons, R. et al. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell75, 1227–1236 (1993). CASPubMed Google Scholar
Umar, A. et al. Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability. J. Biol. Chem.269, 14367–14370 (1994). CASPubMed Google Scholar
Peltomaki, P. & de la Chapelle, A. Mutations predisposing to hereditary nonpolyposis colorectal cancer. Adv. Cancer Res.71, 93–119 (1997). CASPubMed Google Scholar
Modrich, P. Mismatch repair, genetic stability and tumour avoidance. Phil. Trans. R. Soc. Lond. B347, 89–95 (1995). ADSCAS Google Scholar
Kolodner, R. Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev.10, 1433–1442 (1996). CASPubMed Google Scholar
Perucho, M. Cancer of the microsatellite mutator phenotype. Biol. Chem.377, 675–684 (1996). CASPubMed Google Scholar
Dams, E., Van de Kelft, E. J., Martin, J. J., Verlooy, J. & Willems, P. J. Instability of microsatellites in human gliomas. Cancer Res.55, 1547–1549 (1995). CASPubMed Google Scholar
Bhattacharyya, N. P., Skandalis, A., Ganesh, A., Groden, J. & Meuth, M. Mutator phenotypes in human colorectal carcinoma cell lines. Proc. Natl Acad. Sci. USA91, 6319–6323 (1994). ADSCASPubMedPubMed Central Google Scholar
Eshleman, J. R. et al. Increased mutation rate at the hprt locus accompanies microsatellite instability in colon cancer. Oncogene10, 33–37 (1995). CASPubMed Google Scholar
Vogelstein, B. et al. Allelotype of colorectal carcinomas. Science244, 207–211 (1989). ADSCASPubMed Google Scholar
Boige, V. et al. Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype. Cancer Res.57, 1986–1990 (1997). CASPubMed Google Scholar
Seymour, A. B. et al. Allelotype of pancreatic adenocarcinoma. Cancer Res.54, 2761–2764 (1994). CASPubMed Google Scholar
Radford, D. M. et al. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q. Cancer Res.55, 3399–3405 (1995). CASPubMed Google Scholar
Lengauer, C., Kinzler, K. W. & Vogelstein, B. Genetic instability in colorectal cancers. Nature386, 623–627 (1997). ADSCASPubMed Google Scholar
Phear, G., Bhattacharyya, N. P. & Meuth, M. Loss of heterozygosity and base substitution at the APRT locus in mismatch-repair-proficient and -deficient colorectal carcinoma cell lines. Mol. Cell. Biol.16, 6516–6523 (1996). CASPubMedPubMed Central Google Scholar
Bardi, G. et al. Cytogenetic comparisons of synchronous carcinomas and polyps in patients with colorectal cancer. Br. J. Cancer.76, 765–769 (1997). CASPubMedPubMed Central Google Scholar
Silverstein, M. J. Ductal Carcinoma in situ of the Breast(Williams & Wilkins, Baltimore, (1997)). Google Scholar
Bomme, L. et al. Cytogenetic analysis of colorectal adenomas: karyotypic comparisons of synchronous tumors. Cancer Genet. Cytogenet.106, 66–71 (1998). CASPubMed Google Scholar
Aaltonen, L. A. et al. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res.54, 1645–1648 (1994). CASPubMed Google Scholar
Koi, M. et al. Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N′-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res.54, 4308–4312 (1994). CASPubMed Google Scholar
Li, R. et al. Aneuploidy correlated 100% with chemical transformation of Chinese hamster cells. Proc. Natl Acad. Sci. USA94, 14506–14511 (1997). ADSCASPubMedPubMed Central Google Scholar
Harvey, M. et al. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene8, 2457–2467 (1993). CASPubMed Google Scholar
Cross, S. M. et al. Ap53-dependent mouse spindle checkpoint. Science267, 1353–1356 (1995). ADSCASPubMed Google Scholar
Lanni, J. S. & Jacks, T. Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol. Cell. Biol.18, 1055–1064 (1998). CASPubMedPubMed Central Google Scholar
Eshleman, J. R. et al. Chromosome number and structure both are markedly stable in RER colorectal cancers and are not destabilized by mutation of p53. Oncogene17, 719–725 (1998). CASPubMed Google Scholar
Baker, S. J. et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res.50, 7717–7722 (1990). CASPubMed Google Scholar
Auer, G. U., Heselmeyer, K. M., Steinbeck, R. G., Munck-Wikland, E. & Zetterberg, A. D. The relationship between aneuploidy and p53 overexpression during genesis of colorectal adenocarcinoma. Virchows Arch.424, 343–347 (1994). CASPubMed Google Scholar
Hoyt, M. A., Stearns, T. & Botstein, D. Chromosome instability mutants of Saccharomyces cerevisiae that are defective in microtubule-mediated processes. Mol. Cell. Biol.10, 223–234 (1990). CASPubMedPubMed Central Google Scholar
Spencer, F., Gerring, S. L., Connelly, C. & Hieter, P. Mitotic chromosome transmission fidelity mutants in Saccharomyces cerevisiae. Genetics124, 237–249 (1990). CASPubMedPubMed Central Google Scholar
Murray, A. W. The genetics of cell cycle checkpoints. Curr. Opin. Genet. Dev.5, 5–11 (1995). CASPubMed Google Scholar
Nasmyth, K. At the heart of the budding yeast cell cycle. Trends Genet.12, 405–412 (1996). CASPubMed Google Scholar
Elledge, S. J. Cell cycle checkpoints: preventing an identity crisis. Science274, 1664–1672 (1996). ADSCASPubMed Google Scholar
Paulovich, A. G., Toczyski, D. P. & Hartwell, L. H. When checkpoints fail. Cell88, 315–321 (1997). CASPubMed Google Scholar
Cahill, D. P. et al. Mutations of mitotic checkpoint genes in human cancers. Nature392, 300–303 (1998). ADSCASPubMed Google Scholar
Li, Y. & Benezra, R. Identification of a human mitotic checkpoint gene: hsMAD2. Science274, 246–248 (1996). ADSCASPubMed Google Scholar
Taylor, S. S. & McKeon, F. Kenetochore localization of murine Bub1 is required for normal mitotic timing and checkpoint response to spindle damage. Cell89, 727–735 (1997). CASPubMed Google Scholar
Jin, D. Y., Spencer, F. & Jeang, K. T. Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell93, 81–91 (1998). CASPubMed Google Scholar
Hartwell, L. H. & Smith, D. Altered fidelity of mitotic chromosome transmission in cell cycle mutants of S. cerevisiae. Genetics110, 381–395 (1985). CASPubMedPubMed Central Google Scholar
Rotman, G. & Shiloh, Y. ATM: from gene to function. Hum. Mol. Genet.7, 1555–1563 (1998). CASPubMed Google Scholar
Smith, L. et al. Duplication of ATR inhibits MyoD, induces aneuploidy and eliminates radiation-induced G1 arrest. Nature Genet.19, 39–46 (1998). CASPubMed Google Scholar
Zhang, H., Tombline, G. & Weber, B. L. BRCA1, BRCA2, and DNA damage response: collision or collusion? Cell92, 433–436 (1998). CASPubMed Google Scholar
Doxsey, S. The centrosome — a tiny organelle with big potential. Nature Genet.20, 104–106 (1998). CASPubMed Google Scholar
Zhou, H. et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nature Genet.20, 189–193 (1998). CASPubMed Google Scholar
Bischoff, J. R. et al. Ahomologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J.17, 3052–3065 (1998). CASPubMedPubMed Central Google Scholar
Wolf, G. et al. Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer. Oncogene14, 543–549 (1997). CASPubMed Google Scholar
Fukasawa, K., Choi, T., Kuriyama, R., Rulong, S. & Vande Woude, G. F. Abnormal centrosome amplification in the absence of p53. Science271, 1744–1747 (1996). ADSCASPubMed Google Scholar
Johansson, B., Mertens, F. & Mitelman, F. Primary vs. secondary neoplasia-associated chromosomal abnormalities — balanced rearrangements vs. genomic imbalances? Genes Chromosomes Cancer16, 155–163 (1996). CASPubMed Google Scholar
Sturzbecher, H. W., Donzelmann, B., Henning, W., Knippschild, U. & Buchhop, S. p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction. EMBO J.15, 1992–2002 (1996). CASPubMedPubMed Central Google Scholar
Mekeel, K. L. et al. Inactivation of p53 results in high rates of homologous recombination. Oncogene14, 1847–1857 (1997). CASPubMed Google Scholar
Le Beau, M. M. & Rowley, J. D. Chromosomal abnormalities in leukemia and lymphoma: clinical and biological significance. Adv. Hum. Genet.15, 1–54 (1986). CASPubMed Google Scholar
Tycko, B., Palmer, J. D. & Sklar, J. Tcell receptor gene trans-rearrangements: chimeric gamma-delta genes in normal lymphoid tissues. Science245, 1242–1246 (1989). ADSCASPubMed Google Scholar
Hiom, K., Melek, M. & Gellert, M. DNA transposition by the RAG1 and RAG2 proteins: a possible source of oncogenic translocaitons. Cell94, 463–470 (1998). CASPubMed Google Scholar
Tlsty, T. D., Margolin, B. H. & Lum, K. Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbruck fluctuation analysis. Proc. Natl Acad. Sci. USA86, 9441–9445 (1989). ADSCASPubMedPubMed Central Google Scholar
Livingston, L. R. et al. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell70, 923–935 (1992). Google Scholar
Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C. & Wahl, G. M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell70, 937–948 (1992). CASPubMed Google Scholar
Oren, M. Relationship of p53 to the control of apoptotic cell death. Semin. Cancer Biol.5, 221–227 (1994). CASPubMed Google Scholar
Pegram, M. D. et al. Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastic breast cancer refractory to chemotherapy treatment. J. Clin. Oncol.16, 2659–2671 (1998). CASPubMed Google Scholar
Owens, A. H., Coffey, D. S. & Baylin, S. B. Tumor Cell Heterogeneity(Academic, New York, (1982)). Google Scholar
Abbott, D. W., Freeman, M. L. & Holt, J. T. Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells. J. Natl Cancer Inst.90, 978–985 (1998). CASPubMed Google Scholar
Waldman, T., Lengauer, C., Kinzler, K. W. & Vogelstein, B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature381, 713–716 (1996). ADSCASPubMed Google Scholar
Williams, C. et al. Clones of normal keratinocytes and a variety of simultaneously present epidermal neoplastic lesions contain a multitude of p53 gene mutations in a xeroderma pigmentosum patient. Cancer Res.58, 2449–2455 (1998). CASPubMed Google Scholar
Markowitz, S. et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science268, 1336–1338 (1995). ADSCASPubMed Google Scholar